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Conclusions: IMRT with 8 fields is the best technique to obtain the 
goals of the optimization. VMAT can be used when the 'PTV length-
lung length' ratio is low. Tomotherapy doesn’t allow to maintain an 
acceptable PTV coverage if the ratio is high. 
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Purpose/Objective: APBI with external beam RT (EBRT) has emerged 
in the recent years as a treatment option for selected patients with 
early stage breast cancer. Some studies demonstrated the feasibility 
of using volumetric modulated arc therapy (VMAT) for APBI as away to 
improve PTV dose conformity and to deliver lower doses to the 
ipsilateral lung and breast as compared to the conventional 3D-CRT 
techniques. Separately, multiple studies have confirmed the 
effectiveness of breath hold techniques in reducing the cardiac dose 
for left sided breast cancer treated with EBRT. In the search of an 
optimal APBI treatment procedure, we investigate the use of VMAT 
(RapidArc®) and/or voluntary moderately deep inspiration breath hold 
(vmDIBH) in patients treated with external beam APBI.  
Materials and Methods: Three patients were included in this study. 
For each patient 2 CT scans were made, one in free breathing (FB) 
and one in vmDIBH. In each scan, five different tumours were 
contoured in the left breast: upper inner, upper outer, central, lower 
inner, and lower outer. On each CT scan, a conventional 3D-CRT and a 
RapidArc® plan were made using the Varian EclipseTM treatment 
planning system, leading to 60 combinations of patient, tumour site 
and technique. Dose parameters for the PTV, heart, lungs, breasts 
were compared for all plans.  
Results: Preliminary results of this ongoing study show that the 
highest cardiac doses were observed in 3D-CRT plans combined with 
FB for tumors located in the lower inner part of the breast [mean dose 
3.7 ± 0.7 Gy]. With vmDIBH these values were reduced to 1.8± 0.3 Gy. 
The heart volume receiving > 5Gy (V5Gy) was reduced to 7.8% for 
RapidArc® plans in vmDIBH compared with 24.7% and 14.7% in 3D-CRT 
plans in FB and with vmDIBH respectively. For other tumour positions, 
the mean heart dose ranged from 0.2 Gy to 1.3 Gy in FB, which is 
always slightly reduced using vmDIBH to a maximum of 0.5 Gy in all 
plans. RapidArc® plans in breath hold also slightly decreased the 
ipsilateral lung doses [V5Gy= 12.6% ± 1.2%] compared to 3D-CRT 
plans[V5Gy = 15.8% ± 7.3%]. The fraction of the non-target part of the 
ipsilateral breast receiving 50% of the prescribed dose or more was on 
average reduced by 30% in RapidArc® plans as opposed to 3D-CRT 
plans. While, no dose was given to the contralateral breast in 3D-CRT 
plans, RapidArc® plans showed a slight increase in the low dose [V5Gy = 
2.3% ± 0.6%]. In all RapidArc®plans the dose conformity was better 
compared with that of 3D-CRT plans [CI =0.9 ± 0.05 vs. 0.7 ± 0.08]. 
Conclusions: APBI with RapidArc® offers good PTV dose conformity 
and delivers lower doses to lungs and ipsilateral breast compared to 
3D-CRT. This has been at the cost of slightly higher volumes of 
contralateral breast receiving low dose radiation. Patients with 
tumours in the lower inner part of the breast are most likely to 
benefit from combined VMAT and breath hold techniques.  
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Purpose/Objective: Although a lot of tools are available in modern 
treatment planning systems to evaluate 3D dose distributions (DVH, 
biological indices, isodoses in arbitrary planes), the optimality of a 
given IMRT/VMAT plan still depends mainly on the experience of the 
planner and on the way that the optimization problem has been 
formulated in terms of dose objectives. To overcome this bias, we 
have implemented a system that uses our experience in IMRT 
optimization to predict final organ-at-risk (OAR) dose based on 
individual patient geometry. With this technique, we can detect and 
evaluate deviations between predicted and planner results, or 
automatically generate plans with OAR doses consistent with our past 
clinical experience. 
Materials and Methods: In this study we focused on prostate cancer. 
We reviewed all photon IMRT/VMAT plans treated in the past two 
years and found that the final equivalent uniform dose (EUD) for 
bladder and rectum showed a strong linear correlation with the 
overlap volume with the PTV. We used the overlap volume to predict 
plan optimization objectives for rectum and bladder EUD. These 
actions were implemented by user-scripting in our treatment planning 
system (Philips Pinnacle3). This automated technique was applied on 
23 patients to be treated for a prostate cancer in our institution. 
Results: Although they respected clinical goals, significant deviations 
between the operator's final plan and the automated plan (EUD>2Gy) 
were observed in 6 cases indicating non-optimal plans in comparison 
to our past experience. This approach permitted to reduce by half in 
average the planning time, mainly be reducing the number of manual 
iterations loops which are often needed to achieve good quality plans. 
Conclusions: The implementation of this experience-based IMRT 
quality control step has shortened the treatment planning time and 
enables us to easily detect bad optimizations compared to previously 
treated plans. The planner has now the ability to quickly evaluate 
quality of its plan incomparison to previously treated plans. We plan 
to extend this approach to other clinical sites. 
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Purpose/Objective: Increasing the dose delivered via IMRT planning; 
specifically patient specific dose escalation is of current clinical 
interest in improving local control and in turn survival in NSCLC 
patients. Dose escalation usually requires a plan to be created for 
each feasible prescription until an OAR constraint can not be met or a 
plan is optimised using the maximum prescription. To identify the 
optimum prescription for a patient requires a significant amount of 
planning time and the manual creation of multiple redundant plans. 
This study aims to investigate the effectiveness of an automated IMRT 
planning technique in reducing the planning time required by 
minimising the number of plans being created manually.  
Materials and Methods: The automated planning system is operated 
using an in house written java program. Constraints used for inverse 
plan optimisation in Pinnacle v9.0 are iteratively changed using the 
java program. The resulting plan is compared against a static group of 
evaluation objectives to ensure suitability. Clinically relevant 
constraints chosen for optimisation are placed into several levels of 
precedence. Tumour coverage is given the initial priority followed by 
serial organ near-max doses. Once a suitable plan is created the 
system increases the prescription dose and the optimisation is 
repeated using the constraints from the previous iteration as a 
starting point. Figure 1 demonstrates the process used by the system. 
The initial prescription dose of 55.8Gy is increased by adding 
additional fractions of 1.8Gy. The treatment schedule is bi-daily over 
a 4 week period. Dose escalation continues until a maximum 
prescription dose of 79.2Gy is achieved or an OAR objective cannot be 
met. This technique was evaluated by applying it to 5 NSCLC patients. 
Evaluation objectives were selected from an isotoxic lung feasibility 
study. In addition to the evaluation of the dose statistics using a plan 
